To include your compound in the COVID-19 Resource Center, submit it here.

Adventrx, CytRx deal

CytRx disclosed in its 1Q11 earnings that it received 163,000 Adventrx shares in exchange for its 19.1% stake in

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE